Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the Company will release its financial results for the first quarter 2014 on Tuesday, May 13, 2014, before the U.S. financial markets open. Following the release of the financial results, Michael L. Babich, President and Chief Executive Officer, and Darryl S. Baker, Chief Financial Officer, will host a conference call at 11:00 a.m. Eastern Daylight Time. Insys Therapeutics Inc (NASDAQ:INSY) net profit margin is 40.60% and weekly performance is -30.72%. On last trading day company shares ended up $27.63. Analysts mean target price for the company is $62.00. Insys Therapeutics Inc (NASDAQ:INSY) distance from 50-day simple moving average (SMA50) is 35.04%.
CST Brands Inc (NYSE:CST) is scheduled to be issuing its Q114 quarterly earnings data on Tuesday, May 13th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $3.07 billion for the quarter. CST Brands Inc (NYSE:CST) shares advanced 1.62% in last trading session and ended the day on $33.28. CST Gross Margin is 8.60% and its return on assets is 6.40%. CST Brands Inc (NYSE:CST) quarterly performance is 10.34%.
Resolute Energy Corp (NYSE:REN) announced its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.01) by $0.04, Analyst Ratings News reports. The company had revenue of $90.88 million for the quarter, compared to the consensus estimate of $88.25 million. During the same quarter in the prior year, the company posted ($0.05) earnings per share. The company’s quarterly revenue was up 15.2% on a year-over-year basis. Resolute Energy Corp (NYSE:REN) shares moved up 3.02% in last trading session and was closed at $7.50, while trading in range of $7.24 – $7.58. Resolute Energy Corp (NYSE:REN) year to date (YTD) performance is -16.94%.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is reporting for the quarter ending March 31, 2014. The biomedical (gene) company’s consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.07. This value represents a 53.33% increase compared to the same quarter last year. IDRA missed the consensus earnings per share in the 4th calendar quarter of 2013 by -25%. Zacks Investment Research reports that the 2014 Price to Earnings ratio for IDRA is -7.26 vs. an industry ratio of 1.20. Idera Pharmaceuticals Inc (NASDAQ:IDRA) ended the last trading day at $2.54. Company weekly volatility is calculated as 11.39% and price to cash ratio as 7.12. Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a negative weekly performance of -10.25%.
Rice Energy Inc (NASDAQ:RICE) is scheduled to be announcing its Q114 earnings results on Tuesday, May 13th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $76.63 million for the quarter. Rice Energy Inc (NYSE:RICE) on last trading day company shares ended up $28.84.